Here’s what is actually very hot — and what is not — in fintech correct now

Crucial Factors

At Dollars 20/20 in Amsterdam this week, organization-going through fintechs like Airwallex, Payoneer, and ClearBank had been all the rage, whilst client apps these kinds of as Revolut have been nowhere to be identified.
The region that drew the most buzz from Revenue 20/20 attendees was artificial intelligence, with fintech and banking leaders wanting to harness the technology’s opportunity while evaluating the hazards.
Quite a few fintech executives CNBC interviewed spoke of how they’re not intrigued in launching goods customized to crypto as the demand from their prospects is just not there.

Supply

Finance

Kevin Hassett pivots to possible ‘Trump cards’ amid credit card battle with banks

January 16, 2026

Key Points Kevin Hassett told Fox Business that U.S. banks could voluntarily provide credit cards to underserved Americans. President Donald Trump called for banks to cap credit card interest rates at 10%, an idea that has been roundly rejected by industry executives and their lobbyists this week. At least one major credit card issuer and […]

Finance

Stocks making the biggest moves midday: Novo Nordisk, Vistra, GE Vernova, Regions Financial and more

January 16, 2026

Check out some of the companies making headlines in midday trading: Novo Nordisk — The maker of the Wegovy obesity treatment jumped more than 4% as sales of its oral weight loss treatment got off to a strong start. In the first week of its launch, about 1.3% of Wegovy prescriptions were for the oral […]

Finance

Stocks making the biggest moves premarket: PNC, ImmunityBio, Coupang & more

January 16, 2026

Check out the companies making headlines before the bell. ImmunityBio — The biotech company rallied 22%, adding to a 30% rally in the previous session that was sparked by strong guidance for its bladder cancer drug Anktiva. ImmunityBio expects full-year revenue for the drug to jump 700%. Coupang — Shares rose more than 3% after […]